BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iagaru A, Minamimoto R. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer. PET Clin 2018;13:383-93. [PMID: 30100077 DOI: 10.1016/j.cpet.2018.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li X, An C, Zhang W. Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09702-1] [Reference Citation Analysis]
2 Mohd Rohani MF, Zanial AZ, Suppiah S, Phay Phay K, Mohamed Aslum Khan F, Mohamad Najib FH, Mohd Noor N, Arumugam M, Amir Hassan SZ, Vinjamuri S. Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work. Nucl Med Commun 2021;42:9-20. [PMID: 33165258 DOI: 10.1097/MNM.0000000000001306] [Reference Citation Analysis]
3 Binte Alam S, Nii M, Shimizu A, Kobashi S. Spatiotemporal Statistical Shape Model for Temporal Shape Change Analysis of Adult Brain. Curr Med Imaging 2020;16:499-506. [PMID: 32484084 DOI: 10.2174/1573405615666181120141147] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Reinert T, de Souza ABA, Rosa ML, Bedin SR, Barrios CH. Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer. Clin Breast Cancer 2021;21:309-16. [PMID: 33962905 DOI: 10.1016/j.clbc.2021.03.010] [Reference Citation Analysis]
5 Wehrse E, Sawall S, Klein L, Glemser P, Delorme S, Schlemmer HP, Kachelrieß M, Uhrig M, Ziener CH, Rotkopf LT. Potential of ultra-high-resolution photon-counting CT of bone metastases: initial experiences in breast cancer patients. NPJ Breast Cancer 2021;7:3. [PMID: 33398008 DOI: 10.1038/s41523-020-00207-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ulaner GA, Jhaveri K, Chandarlapaty S, Hatzoglou V, Riedl CC, Lewis JS, Mauguen A. Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer. J Nucl Med 2021;62:326-31. [PMID: 32680923 DOI: 10.2967/jnumed.120.247882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Adusumilli P, Nejadhamzeeigilani H, Pitts K, McDermott G, Scarsbrook AF, Vaidyanathan S, Patel CN, Chowdhury FU. Protocol-driven multidetector SPECT/CT: integration of hybrid imaging into the routine workflow of whole-body bone scintigraphy in oncology patients. Clin Radiol 2020;75:79.e1-7. [PMID: 31601386 DOI: 10.1016/j.crad.2019.09.128] [Reference Citation Analysis]
8 Ulaner GA. PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact? American Journal of Roentgenology 2019;213:254-65. [DOI: 10.2214/ajr.19.21177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]